Your experience during screening for SCID
Part of Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at what it feels like for people to go through screening for SCID (a rare immune condition). It may help improve the screening process and support for patients and families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Be able to understand what the study is about and what it may involve
- If you don’t speak English, you can use an interpreter arranged by the research team
- There are special handling steps if a child involved in the study dies after joining, but only to check whether parents want to continue
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study investigates why some people have weak or poorly functioning immune systems. By studying you and your relatives, researchers hope to identify genetic factors that cause these conditions and eventually develop better treatments.
This study follows babies who had a positive newborn screening test for severe combined immunodeficiency (SCID), a rare condition affecting the immune system. The goal is to monitor their health over time to better understand and manage the condition.
This study follows children and adults with SCID and related immune disorders to understand how the illness behaves over time. It also helps researchers learn which testing results and genetic types of SCID match different treatment plans.
This study screens people who may have an inherited immune system condition (like problems with immune cell growth or death) and their blood relatives. The goal is to understand the condition better by collecting blood samples for testing.
This trial tests a new medicine (BP-SCIG 20%) given under the skin to help children and adults with primary immunodeficiency who have trouble making antibodies. It aims to see if the medicine is safe and works well to prevent infections.
This study looks at how the immune system works in people who have abnormal immune function, often shown by unusual or repeated infections or long-lasting inflammation. It may involve tests using blood samples and storage of blood for future research.
Hear when a new Severe Combined Immunodeficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.